Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel

• Bowel Cancer Patients Live Longer Taking Xeloda
• AVAiL Study Shows Longest Survival in Patients With Advanced Non-Small Cell Lung Cancer
• Avastin(R) Gives an Additional 4 Months of Life to Patients With one of the Most Common Types of Lung Cancer
• First Study in Real-Life Setting Confirms That Once-Monthly Mircera Keeps Haemoglobin Levels Within a Tight Range
• Confirmed: Oral Xeloda Should Consistently Replace IV 5-FU in Treatment of all GI Cancers
• New Data Confirms Avastin (R) as the Only Biologic to Demonstrate Overall Survival When Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status
• Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
• New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
• Agendia's Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients
• Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium

Presseportal: Meldung versenden

New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients E-Mail-Adresse des Empfängers: Sie können max.5 Empfänger

Paloma Pharmaceuticals veröffentlicht bahnbrechenden Artikel in Cancer ...

Presented at ASCO Offers Further Hope for Cancer Patients New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients

NEW META-ANALYSIS CONFIRMS SAFETY PROFILE FOR NEORECORMON IN TREATING ...

PRNewswire) - - Data Published in the British Journal of Cancer Reports That NeoRecormon use has no Negative in Treating Anaemia in Cancer Patients

News zu Wirtschaft, Politik, Finanzen, Gesundheit und Gold

New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients Tumour Progression A new meta-analysis of all 12

Bankkaufmann - News

Auf dieser Seite finden Sie Neuigkeiten zum Thema: New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients